PRESS RELEASE published on 01/23/2025 at 00:00, 1 year 4 months ago Onco-Innovations Enters into LOI with Inka Health to Implement AI Technology Toward Cancer Detection and Drug Development Onco-Innovations Limited announces letter of intent with Inka Health Corp. to acquire AI platform for precision oncology. Potential acquisition set to revolutionize drug development processes Artificial Intelligence Precision Oncology Drug Development Onco-Innovations Limited Inka Health Corp.
PRESS RELEASE published on 01/23/2025 at 00:00, 1 year 4 months ago Chiffre d'affaires au S1 2025 de 15,5 M EUR (en intégration globale) Progression des revenus du T2 2025 par rapport au T1 2025 (+45%) Matérialisation des développements en 2025 La Française de l'Énergie affiche un chiffre d'affaires semestriel de 15,5 M€, en progression au T2 2025. Développements solides en énergie verte et gaz, objectifs ambitieux pour 2030 Chiffre D'affaires Energie Verte La Française De L'Énergie Objectifs 2030 Gaz
PRESS RELEASE published on 01/22/2025 at 22:07, 1 year 4 months ago Tamkeen Launches ‘Bahrain Skills and Gender Parity Accelerator’ at Davos Partenariat entre le Fonds du travail de Bahreïn (Tamkeen) et le Forum économique mondial (WEF) pour le lancement de l'Accélérateur des compétences et de la parité des genres à Bahreïn Accélérateur Forum Économique Mondial Bahreïn Fonds Du Travail Genre
PRESS RELEASE published on 01/22/2025 at 22:00, 1 year 4 months ago Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025 Inventiva announces selection of LEGEND trial results evaluating lanifibranor and empagliflozin for oral presentation at EASL SLD Summit 2025, showing positive outcomes in MASH patients with T2D Inventiva MASH Lanifibranor Empagliflozin LEGEND Trial
PRESS RELEASE published on 01/22/2025 at 22:00, 1 year 4 months ago Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025 Les résultats de LEGEND sur la combinaison de lanifibranor avec empagliflozine pour la MASH seront présentés au EASL SLD Summit 2025. Améliorations métaboliques et sécurité démontrées MASH Lanifibranor Empagliflozine LEGEND EASL SLD Summit
PRESS RELEASE published on 01/22/2025 at 20:45, 1 year 4 months ago New World Solutions Provides Corporate Update New World Solutions Inc. provides an update on trading halt and CSE suspension. Postponement of hearing by the Canadian Securities Exchange. Company to offer updates as available Canadian Securities Exchange Trading Halt New World Solutions Inc. CSE Suspension Hearing Postponement
PRESS RELEASE published on 01/22/2025 at 20:00, 1 year 4 months ago Tamkeen Launches ‘Bahrain Skills and Gender Parity Accelerator’ at Davos The Bahrain Labour Fund (Tamkeen) partners with the World Economic Forum to launch the Bahrain Skills and Gender Parity Accelerator at Davos, aiming to close gender skills gap and enhance workforce participation World Economic Forum Gender Parity Bahrain Workforce Skills Training
PRESS RELEASE published on 01/22/2025 at 19:22, 1 year 4 months ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Elior Group S.A. annonce le succès de son offre d'obligations senior à échéance 2030 de 500 millions d'euros 500 Millions D'euros Obligations Senior Elior Group S.A. Échéance 2030
PRESS RELEASE published on 01/22/2025 at 19:22, 1 year 4 months ago Inside Information / Operations of the issuer (acquisitions, sales...) Elior Group S.A. successfully completes offering of €500 million senior notes due 2030 Senior Notes Offering €500 Million 2030 Elior Group S.A.
PRESS RELEASE published on 01/22/2025 at 19:03, 1 year 4 months ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program. Details of transaction and impact on voting rights disclosed Voting Rights London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Own Shares
Published on 05/26/2026 at 17:40, 1 hour 31 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $25 Million Offering of Common Shares
Published on 05/26/2026 at 14:30, 4 hours 41 minutes ago Klondike Gold Announces 2026 Diamond Drilling Program Underway to Update and Expand Gold Mineral Resources
Published on 05/26/2026 at 14:30, 4 hours 41 minutes ago Predictiv AI Announces Strategic Healthcare Partnership and CloudRep AI Integration with Clinicmaster Following Successful Multi-Clinic Pilot Deployments
Published on 05/26/2026 at 14:30, 4 hours 41 minutes ago In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides
Published on 05/26/2026 at 14:15, 4 hours 56 minutes ago Worksport (NASDAQ:WKSP) Secures U.S. Patent For 'Industry-First' Zerofrost Heat Pump Through Its Subsidiary, Terravis Energy
Published on 05/26/2026 at 18:30, 41 minutes ago H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast
Published on 05/26/2026 at 17:45, 1 hour 26 minutes ago FIGEAC AÉRO: EXTENSION DU PARTENARIAT AVEC UN CLIENT AMÉRICAIN
Published on 05/26/2026 at 17:30, 1 hour 41 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)
Published on 05/26/2026 at 17:30, 1 hour 41 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 26 05 2026
Published on 05/26/2026 at 18:39, 31 minutes ago Déclaration des opérations d'achats d'actions réalisées le 18 mai 2026
Published on 05/26/2026 at 18:39, 31 minutes ago Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 1 hour 26 minutes ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 17:45, 1 hour 26 minutes ago EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION
Published on 05/26/2026 at 17:40, 1 hour 31 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.